Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto D Podjarny

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Emerging Topics in Life Sciences|February 2, 2021
Neutron macromolecular crystallographyMatthew P Blakeley, Alberto D Podjarny
Proteins|May 18, 2004
Virtual screening for inhibitors of human aldose reductaseOliver Kraemer, Isabelle Hazemann, Alberto D Podjarny, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Brian Doan, Diane R Sawicki, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 3, 2010
Neutron macromolecular crystallography with LADI-IIIMatthew P Blakeley, Susana C M Teixeira, Isabelle Petit-Haertlein, et al.
ACS Chemical Biology|July 1, 2016
IDD388 Polyhalogenated Derivatives as Probes for an Improved Structure-Based Selectivity of AKR1B10 InhibitorsAlexandra Cousido-Siah, Francesc X Ruiz, Jindřich Fanfrlík, et al.
ACS Chemical Biology|April 29, 2015
The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase InhibitionJindřich Fanfrlík, Francesc X Ruiz, Aneta Kadlčíková, et al.
Journal of Medicinal Chemistry|August 14, 2019
Discovery of <i>N</i>-Substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic Acids as Highly Potent Third-Generation Inhibitors of Human Arginase I and IIMichael C Van Zandt, G Erik Jagdmann, Darren L Whitehouse, et al.
Bioorganic & Medicinal Chemistry|October 7, 2004
Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Evelyn O Sibley, Erin E McCann, et al.
Journal of Medicinal Chemistry|April 29, 2005
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Michael L Jones, David E Gunn, et al.
Journal of Medicinal Chemistry|March 12, 2013
Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injuryMichael C Van Zandt, Darren L Whitehouse, Adam Golebiowski, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Emerging Topics in Life Sciences|February 2, 2021
Neutron macromolecular crystallographyMatthew P Blakeley, Alberto D Podjarny
Proteins|May 18, 2004
Virtual screening for inhibitors of human aldose reductaseOliver Kraemer, Isabelle Hazemann, Alberto D Podjarny, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Brian Doan, Diane R Sawicki, et al.
Acta Crystallographica. Section D, Biological Crystallography|November 3, 2010
Neutron macromolecular crystallography with LADI-IIIMatthew P Blakeley, Susana C M Teixeira, Isabelle Petit-Haertlein, et al.
ACS Chemical Biology|July 1, 2016
IDD388 Polyhalogenated Derivatives as Probes for an Improved Structure-Based Selectivity of AKR1B10 InhibitorsAlexandra Cousido-Siah, Francesc X Ruiz, Jindřich Fanfrlík, et al.
ACS Chemical Biology|April 29, 2015
The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase InhibitionJindřich Fanfrlík, Francesc X Ruiz, Aneta Kadlčíková, et al.
Journal of Medicinal Chemistry|August 14, 2019
Discovery of <i>N</i>-Substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic Acids as Highly Potent Third-Generation Inhibitors of Human Arginase I and IIMichael C Van Zandt, G Erik Jagdmann, Darren L Whitehouse, et al.
Bioorganic & Medicinal Chemistry|October 7, 2004
Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Evelyn O Sibley, Erin E McCann, et al.
Journal of Medicinal Chemistry|April 29, 2005
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Michael L Jones, David E Gunn, et al.
Journal of Medicinal Chemistry|March 12, 2013
Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injuryMichael C Van Zandt, Darren L Whitehouse, Adam Golebiowski, et al.
Pageof 1